Teriparatide News and Research

RSS
Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

ACR’s updated guideline provides recommendations on treatment of glucocorticoid-induced osteoporosis

ACR’s updated guideline provides recommendations on treatment of glucocorticoid-induced osteoporosis

New guidelines recommend evaluation of osteoporosis risk for all postmenopausal women

New guidelines recommend evaluation of osteoporosis risk for all postmenopausal women

Already available drug accelerates healing process after hip fracture

Already available drug accelerates healing process after hip fracture

Molecular signaling pathway could be basis of potential new treatment for osteoporosis

Molecular signaling pathway could be basis of potential new treatment for osteoporosis

New review shows both types of diabetes increase risk of fragility fractures

New review shows both types of diabetes increase risk of fragility fractures

Multidisciplinary experts assess effects of osteoporosis drugs on fracture healing

Multidisciplinary experts assess effects of osteoporosis drugs on fracture healing

Investigational drug abaloparatide-SC may help increase bone mineral density in postmenopausal women

Investigational drug abaloparatide-SC may help increase bone mineral density in postmenopausal women

Combination of adult stem cells and parathyroid hormone may speed healing process for bone fractures

Combination of adult stem cells and parathyroid hormone may speed healing process for bone fractures

Data shows romosozumab better than teriparatide in increasing bone strength in postmenopausal women

Data shows romosozumab better than teriparatide in increasing bone strength in postmenopausal women

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Investigational drug for postmenopausal osteoporosis reduces rate of new spinal fractures

Investigational drug for postmenopausal osteoporosis reduces rate of new spinal fractures

New guidance to prevent bisphosphonate-related atypical femoral fractures

New guidance to prevent bisphosphonate-related atypical femoral fractures

New approach promises better drugs for diabetes and osteoporosis

New approach promises better drugs for diabetes and osteoporosis

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Glide Pharma announces completion of $21.4 million investment round

Glide Pharma announces completion of $21.4 million investment round

Remote controlled microchip successfully delivers drug in early clinical trial

Remote controlled microchip successfully delivers drug in early clinical trial

Nano-enabled intranasal formulation of teriparatide can treat osteoporosis

Nano-enabled intranasal formulation of teriparatide can treat osteoporosis

Unigene acquires exclusive worldwide rights to oral PTH program from GSK

Unigene acquires exclusive worldwide rights to oral PTH program from GSK